BioNexus Gene Lab Corp.

BGLC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.46

-$0.04 (-2.67%)

Sep 22, 2026, 1:41 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.67%

(1D)

Rating

Updated: Aug 27, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.52M

1D Range

1.45 1.48

52W Range

1.07 6.10

Valuation (TTM)

PE -1.19

PB 0.47

EV/EBITDA -0.12

Valuation (NTM)

Forward PE N/A

Forward PEG -0.11

Price Target N/A

Cash Flow

FCF Yield -24.0%

SBC Adj. FCF Yield -24.0%

SBC Impact N/A

Margins

Gross Margin 11.6%

Operating Margin -82.8%

FCF Margin -27.8%

Growth (CAGR)

Revenue 3Y | 5Y -32.9% | -31.7%

Dil EPS 3Y | 5Y 2.8% | -48.8%

FCF 3Y | 5Y 28.2% | -66.6%

Returns

ROA -29.5%

ROE -32.9%

ROIC -32.5%

Financial Health

Net Cash

$3.52M

Current Ratio 6.08

Interest Coverage -407.16

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., spec...

Sector Industrials

Industry Industrial - Distribution

Employees 19

IPO Date Jan 7, 2021

Website www.bionexusgenelab.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.